Findings from OLL1073R-1 and OLS3059 lactic acid bacteria research

(1) Yogurt fermented with OLL1073R-1 and OLS3059 lactic acid bacteria has been confirmed to reduce the risk of catching the common cold and enhance NK activity (human study conducted in seniors from 2005 to 2007).
(2) Yogurt fermented with OLL1073R-1 and OLS3059 lactic acid bacteria has been confirmed to enhance NK activity (animal study conducted in 2005).
(3) Yogurt fermented with OLL1073R-1 and OLS3059 lactic acid bacteria has been confirmed to potentially reduce the risk of influenza infection (animal study conducted in 2011).
(4) Yogurt fermented with OLL1073R-1 and OLS3059 lactic acid bacteria has been confirmed to potentially enhance the effectiveness of influenza vaccines (human study conducted in healthy male university students aged 18 to 25 and healthy adult males and females aged 25 to 59 from 2012 to 2014).
(5) Yogurt fermented with OLL1073R-1 and OLS3059 lactic acid bacteria has been confirmed to increase salivary IgA levels in response to influenza A (H3N2) (human study conducted in seniors in 2014).
(6) Yogurt fermented with OLL1073R-1 and OLS3059 lactic acid bacteria has been confirmed to potentially suppress the temporary decline in immunity (NK activity) and maintain good physical conditions in subjects at high risk of immune dysfunction (human study conducted in male university track-and-field athletes (healthy individuals) aged 18 to 25 in 2012).
(7) Yogurt fermented with OLL1073R-1 and OLS3059 lactic acid bacteria has been confirmed to reduce school absenteeism and improve learning motivation in elementary school students (human study conducted in boys and girls attending 6 elementary schools in Hachioji City, Tokyo, from 2022 to 2023).